#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Diabetes a obezita - Issue 43/2022

6
Editoriál

9
Relationship of glycemic variability and diabetes risk factors in pregnant women

Martina Gáborová, Viera Doničová


16
From the adult type through NIDDM and second type of diabetes – what is coming thereafter?

Oliver Rácz, Eva Sedláková

20
Cardiovascular effect of GLP-1 receptor agonists: meta-analyses suggest a class effect

Peter Novodvorský

24
Use of SGLT2 inhibitors in type 2 diabetics at different stages of the cardiovascular continuum

Zbynek Schroner

30
Cardiorenal benefits of GLP-1 receptor agonists in the treatment of type 2 diabetes mellitus

Rid Dravecká


34
Treatment with biosimilar insulin in routine clinical practice in Slovakia: case reports

Rid Bugáňová, Jana Ročiaková, Jozef Lacka, Zbynek Schroner


39
Co-formulation of insulin degludec and insulin aspartate in realworld clinical practice: the ARISE study

Zbynek Schroner

44
Adipocytokines as possible etiopathogenetic mechanisms leading to a higher incidence of autoimmune thyroiditis in patients with type 2 diabetes mellitus – enlarged study

Štefan Sotak, Zbynek Schroner, Ivica Lazúrová, Ivana Jochmanová, Marek Felš Ci, Darina Petrášová, Izabela Bertková, Miriam Mitníková


52
Effect of GLP-1 receptor agonists on postprandial lipaemia: commentary on a review article

Peter Novodvorský


54
Spomienka na MUDr. Danielu Kuzmovú

55
Virtuálny 26. World Diabetes Congress 2021

Andrea Bukovská

56
7. slovenský deň obezity: v liečbe obezity každý zaváži!

Ubomíra Fábryová


Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#